Futura Medical targets 20 markets for Eroxon - ICYMI

  • Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder talked with Proactive about the company's 2024 financial performance, market expansion, and its product pipeline. Futura Medical PLC reported a strong year in 2024, with CEO James Barder highlighting revenue of £14 million and a maiden profit of £1.3 million—or £3.3 million excluding non-cash items.